Skip to main
AVAH

AVAH Stock Forecast & Price Target

AVAH Analyst Ratings

Based on 9 analyst ratings
Buy
Strong Buy 22%
Buy 44%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Aveanna Healthcare Hldgs is well-positioned for growth in the shift towards value-based care and has seen significant growth in its preferred payor relationships. Despite sustainability challenges and industry risks, the company's recent acquisition and financial performance indicate potential for further expansion and cross-selling opportunities. Risks to the company's rating and price target include government reimbursement policies and workforce availability.

Bears say

Aveanna Healthcare Hldgs is facing potential challenges with maintaining compliance and regulatory standards in the highly regulated home healthcare industry, and with integration and retention of a diverse workforce. Despite strong financial performance and cash flow generation, the company should consider the potential risks and costs associated with these issues in its M&A strategy and focus on maintaining its reputation as a leader in high-quality pediatric care. Additionally, with its focus on value-based care models and cost-efficiency, Aveanna may be well-positioned for long-term success in a rapidly evolving healthcare landscape.

AVAH has been analyzed by 9 analysts, with a consensus rating of Buy. 22% of analysts recommend a Strong Buy, 44% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aveanna Healthcare Holdings and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aveanna Healthcare Holdings (AVAH) Forecast

Analysts have given AVAH a Buy based on their latest research and market trends.

According to 9 analysts, AVAH has a Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $12.89, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $12.89, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aveanna Healthcare Holdings (AVAH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.